Field Director, Autoantibody

Janssen Immunology, a member of Johnson & Johnson's Family of Companies, is recruiting a Field Director, Autoantibody TA. 

At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and balanced lives. We focus on treating, caring and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found. 

We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.

Pioneering gene therapy innovations is a top priority for Janssen. Beginning with the eye, Janssen is investigating gene therapies across varied mechanisms of action, building the case for future applications to other parts of the body. Harnessing our deep experience in pharmaceuticals, combined with Johnson & Johnson's broad ophthalmic footprint, we venture to help more people with retinal diseases see a brighter future.

Janssen’s novel Nipocalimab therapy is an investigative treatment that has the potential to transform treatment of a number of autoantibody and alloantibody diseases by targeting FcRn leading to the degradation of pathogenic IgG. This groundbreaker asset requires a high level of professional engagement to raise disease awareness of the unmet need across 10+ indications, most of which are rare diseases, with a potential first launch in generalized Myasthenia Gravis (gMG).

The Field Director, Autoantibody TA will hire and lead the Medical Science Liaison (MSL) team to execute US medical affairs educational and scientific activities for Nipocalimab. This position reports directly to the Therapeutic Area Lead, Autoantibody, and will serve as a core member of the US Medical Affairs Autoantibody team.

Key responsibilities:  

• Responsible for the hiring, onboarding, training and management of the US regional Autoantibody MSL team including:

  • Create a vision for a MSL team supporting Nipocalimab across multiple TAs and 10+ indications
  • Designing an optimal Field Medical Team Strategy prioritizing launches
  • Build a strategy to strengthen and build Janssen’s external footprint across therapeutic areas within the Autoantibody portfolio
  • Ensuring that team functions according to the Medical Affairs plan and company directives
  • Conducts routine team field visits and 1:1 meetings providing observation and coaching
  • Conducts performance coaching and feedback discussions
  • Serves as a member of the US Medical Affairs leadership team
  • Provides oversight responsibility for team’s training and development
  • Ensures team optimal capacity, field activity level, and field metrics
  • Successfully collaborate with headquarters
  • Ensures each MSL territory plan is strategic, up to date and actionable.
  • Manages the team through special projects and cross functional support activities

• The Field Director is responsible for the recruiting and retention of a diverse team of top talent and will actively implement leadership strategies to inspire and motivate their team members

  • Provide career and succession planning in support of staff reaching their highest potential
  • Plan for scaling and growth of the Autoantibody MSL organization to match increasing number of indications and launches
  • Provide an optimal working environment by promoting/functioning according to Credo values, communication of a clear direction, active listening, respecting diversity, encouraging collaborative partnership, empowering direct reports, follow up on commitments, promoting innovation, and rewarding high performance
  • Responsible for timely completion of administrative duties. Examples include assessment and approval of expense reports, preparation and communication of team metric reports, among others.
  • Co-lead the communication of MSL team achievement updates to appropriate internal partners and levels of management

The successful candidate will have a demonstrated track record of thriving in complexity and ambiguity, and ideally with experience in collaboration with key business partners in rare diseases/immunology in a complex matrix organization.